文献
J-GLOBAL ID:201802220063653359
整理番号:18A0751032
再発性神経膠芽細胞腫患者に対するベバシズマブの有無によるアンジオポエチン阻害ペプチド,トレバナニブの第2相およびバイオマーカー研究【JST・京大機械翻訳】
Phase 2 and biomarker study of trebananib, an angiopoietin-blocking peptibody, with and without bevacizumab for patients with recurrent glioblastoma
著者 (14件):
Reardon David A.
(Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Lassman Andrew B.
(Department of Neurology, Columbia University Medical Center, New York, New York)
,
Schiff David
(Department of Neurology, University of Virginia Medical Center, Charlottesville, Virginia)
,
Yunus Shakeeb A.
(Hematology/Oncology, University of Massachusetts Memorial Medical Center, Worchester, Massachusetts)
,
Gerstner Elizabeth R.
(Department of Neuro-Oncology, Massachusetts General Hospital, Boston, Massachusetts)
,
Cloughesy Timothy F.
(Department of Neurology, University of California, Los Angeles, Los Angeles, California)
,
Lee Eudocia Quant
(Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Gaffey Sarah C.
(Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Barrs Jennifer
(Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Bruno Jennifer
(Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts)
,
Muzikansky Alona
(Biostatistics, Massachusetts General Hospital, Boston, Massachusetts)
,
Duda Daniel G.
(Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts)
,
Jain Rakesh K.
(Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts)
,
Wen Patrick Y.
(Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts)
資料名:
Cancer (Hoboken, N.J.)
(Cancer (Hoboken, N.J.))
巻:
124
号:
7
ページ:
1438-1448
発行年:
2018年
JST資料番号:
D0781B
ISSN:
0008-543X
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)